292 related articles for article (PubMed ID: 32798346)
1. Risk Benefit Analysis in Reference to use of LMWH in COVID-19.
Samajdar SS; Sam PA; Moitra S; Ray Y; Pal J; Joshi SR; Tripathi SK
J Assoc Physicians India; 2020 Sep; 68(9):52-61. PubMed ID: 32798346
[TBL] [Abstract][Full Text] [Related]
2. Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy.
Tang N; Bai H; Chen X; Gong J; Li D; Sun Z
J Thromb Haemost; 2020 May; 18(5):1094-1099. PubMed ID: 32220112
[TBL] [Abstract][Full Text] [Related]
3. D-Dimer, Fibrinogen, and IL-6 in COVID-19 Patients with Suspected Venous Thromboembolism: A Narrative Review.
Eljilany I; Elzouki AN
Vasc Health Risk Manag; 2020; 16():455-462. PubMed ID: 33223833
[TBL] [Abstract][Full Text] [Related]
4. COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation.
Miesbach W; Makris M
Clin Appl Thromb Hemost; 2020; 26():1076029620938149. PubMed ID: 32677459
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic risk and anticoagulant therapy in COVID-19 patients: emerging evidence and call for action.
Kollias A; Kyriakoulis KG; Dimakakos E; Poulakou G; Stergiou GS; Syrigos K
Br J Haematol; 2020 Jun; 189(5):846-847. PubMed ID: 32304577
[TBL] [Abstract][Full Text] [Related]
6. Coagulation abnormalities and thrombosis in patients with COVID-19.
Levi M; Thachil J; Iba T; Levy JH
Lancet Haematol; 2020 Jun; 7(6):e438-e440. PubMed ID: 32407672
[No Abstract] [Full Text] [Related]
7. Prevention and treatment of COVID-19-associated hypercoagulability: Recommendations of the Algerian society of transfusion and hemobiology.
Chekkal M; Deba T; Hadjali S; Lamara H; Oulaa H; Zouai K; Hariti G
Transfus Clin Biol; 2020 Nov; 27(4):203-206. PubMed ID: 33022374
[TBL] [Abstract][Full Text] [Related]
8. Awareness and Prophylaxis of Venous Thromboembolism in Patients with COVID-19: A National Cross-Sectional Survey in Epidemic Era.
Zhang Z; Xi L; Zhang S; Zhang Y; Pang W; Wang Y; Li C; Zhai Z; Wang C
J Atheroscler Thromb; 2020 Oct; 27(10):1123-1137. PubMed ID: 32863290
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy of Coronavirus Disease 2019.
Iba T; Levy JH; Levi M; Connors JM; Thachil J
Crit Care Med; 2020 Sep; 48(9):1358-1364. PubMed ID: 32467443
[TBL] [Abstract][Full Text] [Related]
10. Cerebral venous thrombosis in COVID-19-associated coagulopathy: A case report.
Sugiyama Y; Tsuchiya T; Tanaka R; Ouchi A; Motoyama A; Takamoto T; Hara N; Yanagawa Y
J Clin Neurosci; 2020 Sep; 79():30-32. PubMed ID: 33070913
[TBL] [Abstract][Full Text] [Related]
11. Coagulopathy, thromboembolic complications, and the use of heparin in COVID-19 pneumonia.
Costanzo L; Palumbo FP; Ardita G; Antignani PL; Arosio E; Failla G;
J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):711-716. PubMed ID: 32561465
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 and coagulative axis: review of emerging aspects in a novel disease.
Boccia M; Aronne L; Celia B; Mazzeo G; Ceparano M; D'Agnano V; Parrella R; Valente T; Bianco A; Perrotta F
Monaldi Arch Chest Dis; 2020 May; 90(2):. PubMed ID: 32425013
[TBL] [Abstract][Full Text] [Related]
13. [Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia].
Zhang Y; Cao W; Xiao M; Li YJ; Yang Y; Zhao J; Zhou X; Jiang W; Zhao YQ; Zhang SY; Li TS
Zhonghua Xue Ye Xue Za Zhi; 2020 Apr; 41(4):302-307. PubMed ID: 32447934
[No Abstract] [Full Text] [Related]
14. Guidance for anticoagulation management in venous thromboembolism during the coronavirus disease 2019 pandemic in Poland: an expert opinion of the Section on Pulmonary Circulation of the Polish Cardiac Society.
Kosior DA; Undas A; Kopeć G; Hryniewiecki T; Torbicki A; Mularek-Kubzdela T; Windyga J; Pruszczyk P
Kardiol Pol; 2020 Jun; 78(6):642-646. PubMed ID: 32515570
[TBL] [Abstract][Full Text] [Related]
15. Coagulopathy in COVID-19: Manifestations and management.
Mucha SR; Dugar S; McCrae K; Joseph D; Bartholomew J; Sacha GL; Militello M
Cleve Clin J Med; 2020 Jul; 87(8):461-468. PubMed ID: 32409435
[TBL] [Abstract][Full Text] [Related]
16. [Coagulopathy and COVID-19. Recommendations for a changing reality].
Riveros D; Maymó D; Laviano J; Fornillo FF; Fernández J; Benzadon R; Solimano J; Cacchione R; Riera L; Duarte P; Cazap N; Gotta D; García Altuve J; Valentini R; Dupont J
Medicina (B Aires); 2020; 80(5):505-511. PubMed ID: 33048795
[TBL] [Abstract][Full Text] [Related]
17. Venous Thromboembolism in COVID-19: Towards an Ideal Approach to Thromboprophylaxis, Screening, and Treatment.
Aryal MR; Gosain R; Donato A; Pathak R; Bhatt VR; Katel A; Kouides P
Curr Cardiol Rep; 2020 Jun; 22(7):52. PubMed ID: 32529517
[TBL] [Abstract][Full Text] [Related]
18. COVID-19 and its implications for thrombosis and anticoagulation.
Connors JM; Levy JH
Blood; 2020 Jun; 135(23):2033-2040. PubMed ID: 32339221
[TBL] [Abstract][Full Text] [Related]
19. Prevention and Treatment of Venous Thromboembolism Associated with Coronavirus Disease 2019 Infection: A Consensus Statement before Guidelines.
Zhai Z; Li C; Chen Y; Gerotziafas G; Zhang Z; Wan J; Liu P; Elalamy I; Wang C;
Thromb Haemost; 2020 Jun; 120(6):937-948. PubMed ID: 32316065
[TBL] [Abstract][Full Text] [Related]
20. Fibrinogen and D-dimer variances and anticoagulation recommendations in Covid-19: current literature review.
Hayıroğlu Mİ; Çınar T; Tekkeşin Aİ
Rev Assoc Med Bras (1992); 2020 Jun; 66(6):842-848. PubMed ID: 32696883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
